A joint media briefing with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.
This media briefing will be live streamed over the FDA’s YouTube page.
- Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
- Anne Schuchat, M.D., principal deputy director, CDC
Tues., Apr. 13 at 10:00 a.m. ET
Callers in the United States or Canada may call 800-857-9789. International callers will need to dial 1-517-308-9484. The passcode for all participants is 7809201.
Following the media briefing, a replay will be available on the FDA’s YouTube page.
For other questions about the media briefing, please contact the FDA’s Office of Media Affairs at [email protected].